BioMaxima Balance Sheet Health
Financial Health criteria checks 5/6
BioMaxima has a total shareholder equity of PLN46.6M and total debt of PLN11.5M, which brings its debt-to-equity ratio to 24.7%. Its total assets and total liabilities are PLN74.3M and PLN27.7M respectively.
Key information
24.7%
Debt to equity ratio
zł11.52m
Debt
| Interest coverage ratio | n/a |
| Cash | zł1.00m |
| Equity | zł46.60m |
| Total liabilities | zł27.68m |
| Total assets | zł74.28m |
Recent financial health updates
BioMaxima (WSE:BMX) Is Carrying A Fair Bit Of Debt
Dec 07
BioMaxima (WSE:BMX) Is Carrying A Fair Bit Of Debt
Aug 22BioMaxima (WSE:BMX) Seems To Use Debt Quite Sensibly
Mar 07We Think BioMaxima (WSE:BMX) Can Stay On Top Of Its Debt
Jun 04Does BioMaxima (WSE:BMX) Have A Healthy Balance Sheet?
Feb 18Recent updates
BioMaxima (WSE:BMX) Is Carrying A Fair Bit Of Debt
Dec 07BioMaxima (WSE:BMX) Is Carrying A Fair Bit Of Debt
Aug 22BioMaxima S.A.'s (WSE:BMX) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Jun 08BioMaxima S.A.'s (WSE:BMX) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Apr 21Returns On Capital Are Showing Encouraging Signs At BioMaxima (WSE:BMX)
Sep 07BioMaxima (WSE:BMX) Seems To Use Debt Quite Sensibly
Mar 07We Think BioMaxima (WSE:BMX) Might Have The DNA Of A Multi-Bagger
Feb 02BioMaxima (WSE:BMX) Knows How To Allocate Capital Effectively
Sep 06We Think BioMaxima (WSE:BMX) Can Stay On Top Of Its Debt
Jun 04Does BioMaxima (WSE:BMX) Have A Healthy Balance Sheet?
Feb 18Are BioMaxima's (WSE:BMX) Statutory Earnings A Good Guide To Its Underlying Profitability?
Jan 14
Financial Position Analysis
Short Term Liabilities: BMX's short term assets (PLN23.6M) exceed its short term liabilities (PLN12.9M).
Long Term Liabilities: BMX's short term assets (PLN23.6M) exceed its long term liabilities (PLN14.8M).
Debt to Equity History and Analysis
Debt Level: BMX's net debt to equity ratio (22.6%) is considered satisfactory.
Reducing Debt: BMX's debt to equity ratio has reduced from 86.6% to 24.7% over the past 5 years.
Debt Coverage: BMX's debt is well covered by operating cash flow (41.6%).
Interest Coverage: Insufficient data to determine if BMX's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/21 00:14 |
| End of Day Share Price | 2025/01/21 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
BioMaxima S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|